Affymax (OTCMKTS:AFFY) Shares Break Above Two Hundred Day Moving Average – Should You Sell?

Affymax Inc. (OTCMKTS:AFFY – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0020. Affymax shares last traded at $0.0020, with a volume of 1,500 shares trading hands.

Affymax Stock Performance

Affymax Company Profile

(Get Free Report)

Affymax, Inc was a biopharmaceutical company focused on discovering and developing peptide-based medicines for serious medical conditions. Its research platform was designed to identify novel therapeutic compounds with potential applications across a range of disease areas.

The company’s principal product was peginesatide, marketed in the United States as Omontys. Peginesatide was developed to treat anemia associated with chronic kidney disease and received U.S. regulatory approval in 2012.

See Also

• Five stocks we like better than Affymax
• Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
• Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
• Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
• Oil May Be Stronger Than It Looks—And Diamondback Is on Sale